112 related articles for article (PubMed ID: 10903785)
1. [Loss of heterozygosity as a tool in the evaluation of cancer risk in premalignant lesions of the head and neck].
Soria JC
Bull Cancer; 2000 Jun; 87(6):446. PubMed ID: 10903785
[No Abstract] [Full Text] [Related]
2. Biologic correlates of a biochemoprevention trial in advanced upper aerodigestive tract premalignant lesions.
Papadimitrakopoulou VA; Liu DD; Mao L; Shin DM; El-Naggar A; Ibarguen H; Lee JJ; Hong WK; Hittelman WN
Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1605-10. PubMed ID: 12496051
[TBL] [Abstract][Full Text] [Related]
3. Can molecular assessment improve classification of head and neck premalignancy?
Mao L
Clin Cancer Res; 2000 Feb; 6(2):321-2. PubMed ID: 10690505
[No Abstract] [Full Text] [Related]
4. Genetic progression and clonal relationship of recurrent premalignant head and neck lesions.
Califano J; Westra WH; Meininger G; Corio R; Koch WM; Sidransky D
Clin Cancer Res; 2000 Feb; 6(2):347-52. PubMed ID: 10690509
[TBL] [Abstract][Full Text] [Related]
5. Increased allelic loss in toluidine blue-positive oral premalignant lesions.
Epstein JB; Zhang L; Poh C; Nakamura H; Berean K; Rosin M
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 Jan; 95(1):45-50. PubMed ID: 12539026
[TBL] [Abstract][Full Text] [Related]
6. Correspondence re: M. P. Rosin et al., 3p14 and 9p21 Loss is a simple tool for predicting second oral malignancy at previously treated oral cancer sites. Cancer Res., 62: 6447-6450, 2002.
Braakhuis BJ; Leemans CR; Brakenhoff RH
Cancer Res; 2003 Aug; 63(16):5167-8; author reply 5168-9. PubMed ID: 12941850
[No Abstract] [Full Text] [Related]
7. 3p14 and 9p21 loss is a simple tool for predicting second oral malignancy at previously treated oral cancer sites.
Rosin MP; Lam WL; Poh C; Le ND; Li RJ; Zeng T; Priddy R; Zhang L
Cancer Res; 2002 Nov; 62(22):6447-50. PubMed ID: 12438233
[TBL] [Abstract][Full Text] [Related]
8. Alterations of p16(INK4a) and p14(ARF) in patients with severe oral epithelial dysplasia.
Kresty LA; Mallery SR; Knobloch TJ; Song H; Lloyd M; Casto BC; Weghorst CM
Cancer Res; 2002 Sep; 62(18):5295-300. PubMed ID: 12234999
[TBL] [Abstract][Full Text] [Related]
9. Cyclin D1 and p16 alterations in advanced premalignant lesions of the upper aerodigestive tract: role in response to chemoprevention and cancer development.
Papadimitrakopoulou VA; Izzo J; Mao L; Keck J; Hamilton D; Shin DM; El-Naggar A; den Hollander P; Liu D; Hittelman WN; Hong WK
Clin Cancer Res; 2001 Oct; 7(10):3127-34. PubMed ID: 11595705
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of p53 gene mutation and loss of heterozygosity of 3p, 9p and 17p in precancerous lesions of 29 lung cancer patients.
Nishisaka T; Takeshima Y; Inai K
Hiroshima J Med Sci; 2000 Jun; 49(2):109-16. PubMed ID: 10920577
[TBL] [Abstract][Full Text] [Related]
11. Advances in the diagnosis of oral premalignant and malignant lesions.
Epstein JB; Zhang L; Rosin M
J Can Dent Assoc; 2002 Nov; 68(10):617-21. PubMed ID: 12410942
[TBL] [Abstract][Full Text] [Related]
12. Multiple squamous cell carcinomas of the head and neck show different phenotypes of allelic loss patterns suggesting different clonal origin of carcinogenesis.
Shiga K; Ogawa T; Yoshida F; Matsuura K; Tateda M; Saijo S; Miyagi T; Kobayashi T
Anticancer Res; 2003; 23(5A):3911-5. PubMed ID: 14666696
[TBL] [Abstract][Full Text] [Related]
13. Leukoplakia: molecular understanding of pre-malignant lesions and implications for clinical management.
Mao L
Mol Med Today; 1997 Oct; 3(10):442-8. PubMed ID: 9358471
[TBL] [Abstract][Full Text] [Related]
14. Current status of biomarkers in head and neck cancer.
Chang SS; Califano J
J Surg Oncol; 2008 Jun; 97(8):640-3. PubMed ID: 18493942
[TBL] [Abstract][Full Text] [Related]
15. Allelic losses in OraTest-directed biopsies of patients with prior upper aerodigestive tract malignancy.
Guo Z; Yamaguchi K; Sanchez-Cespedes M; Westra WH; Koch WM; Sidransky D
Clin Cancer Res; 2001 Jul; 7(7):1963-8. PubMed ID: 11448911
[TBL] [Abstract][Full Text] [Related]
16. Allelic imbalance on chromosomes 3p, 9p and 17p in malignant progression of laryngeal mucosa.
Guo T; Sun JW; Lv QP; Li XG
J Laryngol Otol; 2008 Jan; 122(1):72-7. PubMed ID: 17498326
[TBL] [Abstract][Full Text] [Related]
17. Multiple oral squamous epithelial lesions: are they genetically related?
Jang SJ; Chiba I; Hirai A; Hong WK; Mao L
Oncogene; 2001 Apr; 20(18):2235-42. PubMed ID: 11402318
[TBL] [Abstract][Full Text] [Related]
18. Phenotype and genotype of advanced premalignant head and neck lesions after chemopreventive therapy.
Mao L; El-Naggar AK; Papadimitrakopoulou V; Shin DM; Shin HC; Fan Y; Zhou X; Clayman G; Lee JJ; Lee JS; Hittelman WN; Lippman SM; Hong WK
J Natl Cancer Inst; 1998 Oct; 90(20):1545-51. PubMed ID: 9790547
[TBL] [Abstract][Full Text] [Related]
19. Genetic syndromes of the head and neck associated with cancer: what else to look for in the presence of positive orofacial findings.
Salinas CF
Compend Contin Educ Dent; 2002 Dec; 23(12 Suppl):30. PubMed ID: 12790000
[No Abstract] [Full Text] [Related]
20. p53 protein accumulation and genomic instability in head and neck multistep tumorigenesis.
Shin DM; Charuruks N; Lippman SM; Lee JJ; Ro JY; Hong WK; Hittelman WN
Cancer Epidemiol Biomarkers Prev; 2001 Jun; 10(6):603-9. PubMed ID: 11401909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
